Healthcare Triangle financials
$0.6615−11.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $13.9M | $11.7M | $33.2M | $45.9M | $35.3M |
| Gross profit | $1.9M | $2.9M | $6.8M | $11.3M | $10.5M |
| Gross margin | 13.6% | 24.7% | 20.4% | 24.6% | 29.8% |
| Operating income | -$9.8M | -$4.8M | -$7.7M | -$14.7M | -$5.4M |
| Net income | -$9.5M | -$6.0M | -$8.7M | -$14.4M | -$5.9M |
| Net margin | −68.1% | −51.0% | −26.2% | −31.3% | −16.9% |
| Diluted EPS | $-152.90 | $-16909.30 | $-31075.20 | $-57967.20 | $-30178.80 |
| EBITDA | -$9.1M | -$3.9M | -$4.4M | -$9.0M | -$3.8M |
| Operating cash flow | -$16.5M | -$1.1M | -$2.2M | -$5.4M | -$10.2M |
| Free cash flow | -$16.8M | -$1.1M | -$2.2M | -$5.4M | — |
| Diluted shares | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $7.6M | $20.0K | $1.2M | $1.3M | $1.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $10.7M | $2.6M | $3.9M | $2.7M | $2.2M |
| Total assets | $22.7M | $2.0M | $6.9M | $13.3M | $24.6M |
| Total liabilities | $12.8M | $7.1M | $8.2M | $7.2M | $8.5M |
| Shareholders' equity | $9.9M | -$5.1M | -$1.4M | $6.0M | $16.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology